476 related articles for article (PubMed ID: 29963554)
1. Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models.
Torres Crigna A; Daniele C; Gamez C; Medina Balbuena S; Pastene DO; Nardozi D; Brenna C; Yard B; Gretz N; Bieback K
Front Med (Lausanne); 2018; 5():179. PubMed ID: 29963554
[TBL] [Abstract][Full Text] [Related]
2. Clinically Relevant Mesenchymal Stem/Stromal Cell Sheet Transplantation Method for Kidney Disease.
Oka M; Kameishi S; Cho YK; Song SU; Grainger DW; Okano T
Tissue Eng Part C Methods; 2023 Feb; 29(2):54-62. PubMed ID: 36719774
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy.
Fiori A; Terlizzi V; Kremer H; Gebauer J; Hammes HP; Harmsen MC; Bieback K
Immunobiology; 2018 Dec; 223(12):729-743. PubMed ID: 29402461
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence.
Peired AJ; Sisti A; Romagnani P
Stem Cells Int; 2016; 2016():4798639. PubMed ID: 27721835
[TBL] [Abstract][Full Text] [Related]
5. The use of stem cells in kidney disease.
Chhabra P; Brayman KL
Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
[TBL] [Abstract][Full Text] [Related]
6. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury.
Tögel F; Cohen A; Zhang P; Yang Y; Hu Z; Westenfelder C
Stem Cells Dev; 2009 Apr; 18(3):475-85. PubMed ID: 18564903
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia preconditioning increases the ability of healthy but not diabetic rat-derived adipose stromal/stem cells (ASC) to improve histological lesions of streptozotocin-induced diabetic nephropathy.
Carmona M; Paco-Meza LM; Ortega R; Cañadillas S; Caballero-Villarraso J; Blanco A; Herrera C
Pathol Res Pract; 2022 Feb; 230():153756. PubMed ID: 35032832
[TBL] [Abstract][Full Text] [Related]
8. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells.
Sávio-Silva C; Beyerstedt S; Soinski-Sousa PE; Casaro EB; Balby-Rocha MTA; Simplício-Filho A; Alves-Silva J; Rangel ÉB
Stem Cells Int; 2020; 2020():8833725. PubMed ID: 33505469
[TBL] [Abstract][Full Text] [Related]
10. Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy.
Li H; Rong P; Ma X; Nie W; Chen C; Yang C; Zhang J; Dong Q; Wang W
Life Sci; 2018 Dec; 215():113-118. PubMed ID: 30399376
[TBL] [Abstract][Full Text] [Related]
11. Clinical Prospect of Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles in Kidney Disease: Challenges and the Way Forward.
Kosanović M; Milutinović B; Kutzner TJ; Mouloud Y; Bozic M
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514097
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.
Morata-Tarifa C; Macías-Sánchez MDM; Gutiérrez-Pizarraya A; Sanchez-Pernaute R
Stem Cell Res Ther; 2020 Feb; 11(1):64. PubMed ID: 32070420
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.
Fukumitsu M; Suzuki K
J Cardiol; 2019 Oct; 74(4):304-312. PubMed ID: 31109735
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of stromal cells of non-renal or renal origin in experimental chronic kidney disease.
Rota C; Morigi M; Cerullo D; Introna M; Colpani O; Corna D; Capelli C; Rabelink TJ; Leuning DG; Rottoli D; Benigni A; Zoja C; Remuzzi G
Stem Cell Res Ther; 2018 Aug; 9(1):220. PubMed ID: 30107860
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis.
Matthay MA; Pati S; Lee JW
Stem Cells; 2017 Feb; 35(2):316-324. PubMed ID: 27888550
[TBL] [Abstract][Full Text] [Related]
16. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.
Griffin TP; Martin WP; Islam N; O'Brien T; Griffin MD
Curr Diab Rep; 2016 May; 16(5):42. PubMed ID: 27007719
[TBL] [Abstract][Full Text] [Related]
17. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis.
Maria AT; Toupet K; Maumus M; Fonteneau G; Le Quellec A; Jorgensen C; Guilpain P; Noël D
J Autoimmun; 2016 Jun; 70():31-9. PubMed ID: 27052182
[TBL] [Abstract][Full Text] [Related]
18. Does the route matter? A preclinical review of mesenchymal stromal cell delivery to the kidney.
Kresse JC; Gregersen E; Atay JCL; Eijken M; Nørregaard R
APMIS; 2023 Dec; 131(12):687-697. PubMed ID: 37750005
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine.
Miceli V; Bulati M; Iannolo G; Zito G; Gallo A; Conaldi PG
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466583
[TBL] [Abstract][Full Text] [Related]
20. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30939749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
